Drug Monitoring of Therapy with Midazolam in Patients with ARDS: A Single-Center Prospective Study
: The results show that routine monitoring of midazolam does not provide additional clinical value. However, further studies are needed in high-risk groups. Despite the high mortality rate in the ICU for patients with severe respiratory failure, the six-month survival rate for discharged patients was high, exceeding 80%.
Authors
- Bogusław Okopień (ORCID: https://orcid.org/0000-0001-7228-2906)
- Marek Grochla (ORCID: https://orcid.org/0000-0001-6508-9307)
- Marcin Basiak (ORCID: https://orcid.org/0000-0003-0674-5612)
- Piotr Knapik (ORCID: https://orcid.org/0000-0002-1058-1502)
Institutions
- Medical University of Silesia (PL)
- University of Silesia in Katowice (PL)
Publication Details
- Journal
- Medicina
- Published
- 2026-04-13
- DOI
- https://doi.org/10.3390/medicina62040742
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Narodowe Centrum Nauki